New SEC Form D filing
Caspian Therapeutics, Inc., 2026-09-23
A new SEC Form D private-offering notice from San Diego, CA, a $50,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Biotech spun out of Kura Oncology developing menin inhibitors, including KO-7246, for diabetes and cardiometabolic disease
Filed 2026-09-23Filed to raise $50,000,000First money in 2026-09-08Raised so far $50,000,000HQ (as filed) San Diego, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified caspiantherapeutics.com↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Mojave Energy Systems, Inc., 2026-09-23, $27.3M, Sunnyvale, CA
- Swift Cardiovascular, Inc., 2026-09-24, $1.5M, Durham, NC
- Fenix Space, Inc., 2026-09-23, $6M, San Bernardino, CA
- Seraxis Holdings, Inc., 2026-09-24, $10M, Germantown, MD
- GridX, Inc., 2026-09-23, $7.5M, Walnut Creek, CA
- Uvantis Therapeutics, Inc., 2026-09-23, $5M, Columbia, MD
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.